BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

751 related articles for article (PubMed ID: 12396225)

  • 1. Second-line controller therapy for persistent asthma uncontrolled on inhaled corticosteroids: the step 3 dilemma.
    Lipworth BJ; Jackson CM
    Drugs; 2002; 62(16):2315-32. PubMed ID: 12396225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exercise-induced bronchoconstriction in asthmatic children: a comparative systematic review of the available treatment options.
    Grzelewski T; Stelmach I
    Drugs; 2009 Aug; 69(12):1533-53. PubMed ID: 19678711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of leukotriene receptor antagonists (LTRAs) as complementary therapy in asthma.
    Bjermer L; Diamant Z
    Monaldi Arch Chest Dis; 2002 Feb; 57(1):76-83. PubMed ID: 12174707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of moderate persistent asthma: inhalation corticosteroids in combination with long acting beta 2-adrenergic agonists (bronchodilators) then with leukotriene receptor antagonists (anti-inflammatory agents); the 'step-3-dilemma'].
    Diamant Z; Dekhuijzen PN
    Ned Tijdschr Geneeskd; 2003 Aug; 147(35):1681-5. PubMed ID: 14513539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment options for initial maintenance therapy of persistent asthma: a review of inhaled corticosteroids and leukotriene receptor antagonists.
    Creticos PS
    Drugs; 2003; 63 Suppl 2():1-20. PubMed ID: 14984077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Status of leukotrienes in the pathophysiology of asthma. Necessity for antileukotrienes treatment].
    Fal AM; Kopeć A
    Pneumonol Alergol Pol; 2010; 78(1):68-73. PubMed ID: 20162521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefit-risk assessment of long-acting beta2-agonists in asthma.
    Jackson CM; Lipworth B
    Drug Saf; 2004; 27(4):243-70. PubMed ID: 15003036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of leukotriene receptor antagonists are associated with a similar risk of asthma exacerbations as inhaled corticosteroids.
    Wu AC; Li L; Fung V; Kharbanda EO; Larkin EK; Vollmer WM; Butler MG; Miroshnik I; Rusinak D; Davis RL; Hartert T; Weiss ST; Lieu TA
    J Allergy Clin Immunol Pract; 2014; 2(5):607-13. PubMed ID: 25213056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of tiotropium, long-acting β
    Vogelberg C; Goldstein S; Graham L; Kaplan A; de la Hoz A; Hamelmann E
    Respir Res; 2020 Jan; 21(1):19. PubMed ID: 31931792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacy of inhaled corticosteroids and antileukotriene drugs in asthma.
    Smith LJ
    BioDrugs; 2001; 15(4):239-49. PubMed ID: 11437689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing Asthma in Adolescents and Adults: 2020 Asthma Guideline Update From the National Asthma Education and Prevention Program.
    Cloutier MM; Dixon AE; Krishnan JA; Lemanske RF; Pace W; Schatz M
    JAMA; 2020 Dec; 324(22):2301-2317. PubMed ID: 33270095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omalizumab: an update on efficacy and safety in moderate-to-severe allergic asthma.
    Chipps BE; Figliomeni M; Spector S
    Allergy Asthma Proc; 2012; 33(5):377-85. PubMed ID: 23026179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antileukotrienes in the treatment of asthma and allergic rhinitis.
    Ribeiro JD; Toro AA; Baracat EC
    J Pediatr (Rio J); 2006 Nov; 82(5 Suppl):S213-21. PubMed ID: 17136298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Asthma exacerbations: pharmacological prevention].
    Grassin-Delyle S; Girodet PO
    Rev Mal Respir; 2012 Feb; 29(2):232-44. PubMed ID: 22405116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of inhaled corticosteroids, leukotriene receptor antagonists, or both, plus long-acting beta2-agonists on asthma pathophysiology: a review of the evidence.
    Vignola AM
    Drugs; 2003; 63 Suppl 2():35-51. PubMed ID: 14984079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New and developing non-adrenoreceptor small molecule drugs for the treatment of asthma.
    Thomson NC
    Expert Opin Pharmacother; 2017 Feb; 18(3):283-293. PubMed ID: 28099820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addition of leukotriene receptor antagonists to inhaled corticosteroids improved QOL of patients with bronchial asthma surveyed in suburban Tokyo, Japan.
    Ohshima N; Matsui H; Matsui Y; Kawashima M; Shimada M; Higaki N; Shoji S; Wada H; Fujita A; Watanabe H; Yamaguchi N; Matsuoka R; Oki K; Takahashi H; Suzuki M; Yamazaki H; Yoshizawa M; Goto H
    Allergol Int; 2011 Dec; 60(4):473-81. PubMed ID: 21681017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tiotropium add-on to inhaled corticosteroids versus addition of long-acting β
    Buhl R; FitzGerald JM; Busse WW
    Respir Med; 2018 Oct; 143():82-90. PubMed ID: 30261998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prescribing patterns of asthma controller therapy for children in UK primary care: a cross-sectional observational study.
    Thomas M; Murray-Thomas T; Fan T; Williams T; Taylor S
    BMC Pulm Med; 2010 May; 10():29. PubMed ID: 20470409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Principal findings of systematic reviews for chronic treatment in childhood asthma.
    Castro-Rodriguez JA; Rodrigo GJ; Rodriguez-Martinez CE
    J Asthma; 2015 May; 52(4):407-16. PubMed ID: 25275887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.